Commentary
Oral Fluoroprimidine Based Chemotherapy of HER2 Positive Gastric Cancer
Osawa H*, Shiobara H, Akashi H, Taura Y, Endo H, Ogiya K, Saeki I, Takahashi S, Shimojyu K
Department of Oncology and Hematology, Edogawa Hospital, Tokyo, Japan
- *Corresponding Author:
- Hiroshi Osawa
Department of Oncology and Hematology
Edogawa Hospital, 2-24-18 Higashi-Kiowa, Edogawa, Tokyo, Japan
Tel: +81-3-3673-1221
E-mail: oosawa@edogawa.or.jp
Received date: August 26, 2017; Accepted date: September 06, 2017; Published date: September 13, 2017
Citation: Osawa H, Shiobara H, Akashi H, Taura Y, Endo H, et al. (2017) Oral Fluoroprimidine Based Chemotherapy of HER2 Positive Gastric Cancer. J Mol Immunol 2:113.
Copyright: © 2017 Osawa H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
